XML 103 R78.htm IDEA: XBRL DOCUMENT
v3.25.3

FAIR VALUE OF FINANCIAL INSTRUMENTS | 9 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2025 | Sep. 30, 2024
FAIR VALUE OF FINANCIAL INSTRUMENTS |  |
FAIR VALUE OF FINANCIAL INSTRUMENTS | NOTE I – FAIR VALUE OF FINANCIAL INSTRUMENTS The Company’s financial instruments at fair value are measured on a recurring basis. Related unrealized gains or losses are recognized in unrealized gain (loss) on change in fair value of the warrants classified as a liability in the condensed consolidated statements of operations. For additional disclosures regarding methods and assumptions used in estimating fair values of these financial instruments, see Note B. The following tables present the fair value of the Company’s financial instruments as of June 30, 2025 ​
​ | ​ | ​ | ​
​ | ​ | Fair value at
​ |  | June 30, 2025
Liabilities: | ​ | ​ | ​
Common Warrants | ​ | $ | 100
Series A Warrants | ​ | $ | 10
Series A Warrants - modified | ​ | $ | 50
Private Common Warrants | ​ | $ | 1,000
​ NOTE I – FAIR VALUE OF FINANCIAL INSTRUMENTS, continued The fair value of the warrants classified as a liability as of June 30, 2025, was determined using the Black Scholes and Probability Weighted Expected Return models. The fair value for the warrants classified as a liability as of June 30, 2025, was calculated using the following assumptions: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ |  | ​ | ​ |  | Series A |  | Private |
​ | ​ | Common | ​ | Series A | ​ | Warrants – | ​ | Common |
​ | ​ | Warrants | ​ | Warrants | ​ | modified | ​ | Warrants |
Stock price | ​ | $ | 5.15 | ​ | $ | 5.15 | ​ | $ | 5.15 | ​ | $ | 5.15 | ​
Exercise price | ​ | $ | 9,135 | ​ | $ | 60,000 | ​ | $ | 9,135 | ​ | $ | 9,135 | ​
Dividend yield | ​ |  | 0 | % |  | 0 | % |  | 0 | % |  | 0 | %
Selected Volatility | ​ |  | 187.50 | % |  | 187.50 | % |  | 187.50 | % |  | 172.50 | %
Risk free rate | ​ |  | 3.69 | % |  | 3.72 | % |  | 3.69 | % |  | 3.72 | %
Fundamental transaction probability | ​ |  | 30.00 | % |  | 30.00 | % |  | 30.00 | % |  | 30.00 | %
Fundamental transaction Black Scholes Volatility | ​ |  | 214.00 | % |  | 100.00 | % |  | 214.0 | % |  | 183.30 | %
Fundamental transaction timing | ​ |  | 12/31/2025 | ​ |  | 12/31/2025 | ​ |  | 12/31/2025 | ​ |  | 12/31/2025 | ​
​ The Company did not have any assets or liabilities categorized as Level 1 or 2 as of June 30, 2025. The change in fair value of the Common Warrants (issued in February 2024), the Series A Warrants (issued in February 2022) and the Private Common Warrants (issued in February 2024) for the three-month period ended June 30, 2025, is summarized as follows: ​ ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | Series A | ​ | Private | ​ | ​
​ | ​ | Common | ​ | Series A | ​ | Warrants- | ​ | Common | ​ | ​
​ |  | Warrants |  | Warrants |  | modified |  | Warrants |  | Totals
Fair value at April 1, 2025 | ​ | $ | 1,000 | ​ | $ | 140 |  | ​ | 430 |  | ​ | 6,000 | ​ | $ | 7,570
Change in fair value | ​ |  | (900) | ​ |  | (130) |  | ​ | (380) |  | ​ | (5,000) | ​ |  | (6,410)
Fair Value at June 30, 2025 | ​ | $ | 100 | ​ | $ | 10 | ​ | $ | 50 | ​ | $ | 1,000 | ​ | $ | 1,160
​ The change in fair value of the Common Warrants, the Series A Warrants and the Private Common Warrants for the nine-month period ended June 30, 2025 is summarized as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | ​ | Series A | ​ | Private | ​ | ​
​ | ​ | Common | ​ | Series A | ​ | Warrants- | ​ | Common | ​ | ​
​ | ​ | Warrants |  | Warrants |  | modified |  | Warrants |  | Totals
Fair value at October 1, 2024 | ​ | $ | 27,000 | ​ | $ | 15,000 |  | $ | 16,000 |  | $ | 262,000 | ​ | $ | 320,000
Change in fair value | ​ | ​ | (26,900) | ​ | ​ | (14,990) | ​ |  | (15,950) | ​ |  | (261,000) | ​ | ​ | (318,840)
Fair Value at June 30, 2025 | ​ | $ | 100 | ​ | $ | 10 | ​ | $ | 50 | ​ | $ | 1,000 | ​ | $ | 1,160
​ | NOTE L – FAIR VALUE OF FINANCIAL INSTRUMENTS The Company’s financial instruments at fair value are measured on a recurring basis. Related unrealized gains or losses are recognized in unrealized gain (loss) on change in fair value of the warrants classified as a liability in the consolidated statements of operations. For additional disclosures regarding methods and assumptions used in estimating fair values of these financial instruments, see Note B. The following table presents the fair value of the Company’s financial instruments as of September 30, 2024 and summarizes the significant unobservable inputs in fair value measurement of Level 3 financial assets and liabilities as of September 30, 2024. The Company did not have any assets or liabilities categorized as Level 1 or 2 as of September 30, 2024. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fair value at | ​ | Valuation | ​ | Unobservable | ​ | Volatility | ​
​ |  | September 30, 2024 |  | Technique |  | Input |  | Input | ​
Liabilities: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Common Warrants | ​ | $ | 27,000 | ​ | Monte Carlo simulation | ​ | Annualized volatility | ​ | 157.50 | %
Series A Warrants | ​ | $ | 15,000 | ​ | Monte Carlo simulation | ​ | Annualized volatility | ​ | 167.50 | %
Series A Warrants - modified | ​ | $ | 16,000 | ​ | Monte Carlo simulation | ​ | Annualized volatility | ​ | 157.50 | %
Private Common Warrants | ​ | $ | 262,000 | ​ | Monte Carlo simulation | ​ | Annualized volatility | ​ | 167.50 | %
​ The change in fair value of the Common Warrants for the fiscal year ended September 30, 2024 is summarized as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | ​ | ​ | ​ | Series A | ​ | Private |  | ​ | ​
​ | ​ | Common | ​ | Series A | ​ | Warrants- | ​ | Common | ​ | ​ | ​
​ |  | Warrants |  | Warrants |  | modified |  | Warrants |  | Totals
Fair value at October 1, 2023 | ​ | $ | 1,468,000 | ​ | $ | 1,971,900 | ​ | $ | 845,100 | ​ | $ | — | ​ | $ | 4,285,000
Fair value at February 2, 2024 | ​ |  | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 5,071,000 | ​ |  | 5,071,000
Change in fair value-warrant modification | ​ |  | 230,000 | ​ | ​ | — | ​ | ​ | 164,000 | ​ | ​ | — | ​ |  | 394,000
Change in fair value | ​ | ​ | (1,671,000) | ​ | ​ | (1,956,900) | ​ | ​ | (993,100) | ​ | ​ | (4,809,000) | ​ | ​ | (9,430,000)
Fair Value at September 30, 2024 | ​ | $ | 27,000 | ​ | $ | 15,000 | ​ | $ | 16,000 | ​ | $ | 262,000 | ​ | $ | 320,000
​

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 940 -SubTopic 820 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration